Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro three times daily (TID) as add-on therapy when glycemic control is sub-optimal with titrated basal insulin glargine and metformin.Methods: The analysis was based on the recent 4B Study, which compared exenatide BID and lispro TID as add-on therapies in subjects with type 2 diabetes insufficiently controlled, despite titrated insulin glargine. The Cardiff Diabetes Model was used to simulate patient costs and health benefits beyond the 4B Study. The Swedish healthcare perspective was adopted for this analysis; costs are reported in (sic)EUR to aid interpretation. The main outcome measure was the cost per quality-adjusted life-year (QALY) gaine...
Objective, To evaluate the cost-effectiveness of exenatide twice daily, BID, vs bolus insulin lispro...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) versus bolus insulin li...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) versus bolus insulin li...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective, To evaluate the cost-effectiveness of exenatide twice daily, BID, vs bolus insulin lispro...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) versus bolus insulin li...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) versus bolus insulin li...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro...
Objective, To evaluate the cost-effectiveness of exenatide twice daily, BID, vs bolus insulin lispro...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...
Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis ...